Medicine Man Technologies Inc (SHWZ)
0.6201
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Medicine Man Technologies Debt to Equity Ratio: 1.314 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2023 | 1.314 |
September 30, 2023 | 1.064 |
June 30, 2023 | 1.050 |
March 31, 2023 | 0.9781 |
December 31, 2022 | 0.9668 |
September 30, 2022 | 0.7829 |
June 30, 2022 | 0.7713 |
March 31, 2022 | 1.019 |
December 31, 2021 | 0.7308 |
September 30, 2021 | 0.5044 |
June 30, 2021 | 0.4846 |
March 31, 2021 | 0.4963 |
December 31, 2020 | 0.4525 |
September 30, 2020 | 0.00 |
June 30, 2020 | 0.00 |
March 31, 2020 | 0.00 |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.00 |
June 30, 2019 | 0.00 |
Date | Value |
---|---|
March 31, 2019 | 0.00 |
December 31, 2018 | 0.00 |
September 30, 2018 | 0.00 |
June 30, 2018 | 0.00 |
March 31, 2018 | 0.00 |
December 31, 2017 | 0.0054 |
September 30, 2017 | 0.0705 |
June 30, 2017 | 0.1104 |
March 31, 2017 | -62.88 |
December 31, 2016 | -2.152 |
September 30, 2016 | 0.5254 |
June 30, 2016 | 0.00 |
March 31, 2016 | 0.00 |
December 31, 2015 | 0.00 |
September 30, 2015 | 0.00 |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2019
1.314
Maximum
Dec 2023
0.5587
Average
0.5044
Median
Sep 2021
Debt to Equity Ratio Benchmarks
NovaBay Pharmaceuticals Inc | 0.3431 |
Palatin Technologies Inc | 0.00 |
iBio Inc | -- |
Theriva Biologics Inc | -- |
Oragenics Inc | -- |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 358.14M |
Total Liabilities (Quarterly) | 238.85M |
Shareholders Equity (Quarterly) | 119.29M |
Current Ratio | 0.9677 |
Net Debt Paydown Yield | -14.36% |